| 61/194 | US=26-A / Radioterapia Woo SY. The brain and spinal cord. In: Cox JD, Ang KK. Radiation oncology: rationale, technique, results. 9ª ed. Philadelphia: Elsevier Mosby, 2010. p. 835-71. ISBN 978-0-323-04971-9. CEREBRO; MEDULA ESPINHAL; SISTEMA NERVOSO CENTRAL; CANCER DO SISTEMA NERVOSO CENTRAL; MEDULOBLASTOMA; ASTROCITOMA; GLIOMA DO TRONCO CEREBRAL; EPENDIMOMA; CRANIOFARINGIOMA; TUMORES NEUROECTODERMAL; GLIOMAS; OLIGODENDROGLIOMA; MENINGIOMA; LINFOMA; CANCER DO CEREBRO; CANCER DE MEDULA ESPINHAL |
| 62/194 | US=26-A / Radioterapia Dabaja B, Ha CS, Cox JD. Leukemias and lymphomas. In: Cox JD, Ang KK. Radiation oncology: rationale, technique, results. 9ª ed. Philadelphia: Elsevier Mosby, 2010. p. 875-911. ISBN 978-0-323-04971-9. LEUCEMIA; LINFOMA; CELULAS-TRONCO HEMATOPOETICAS; MEDULA OSSEA; IRRADIACAO; LINFOMA HODGKIN; LINFOMA NAO HODGKIN |
| 63/194 | US=26-A / Radioterapia Lewis VO. The bone. In: Cox JD, Ang KK. Radiation oncology: rationale, technique, results. 9ª ed. Philadelphia: Elsevier Mosby, 2010. p. 915-39. ISBN 978-0-323-04971-9. OSSO; CANCER DE OSSO; IRRADIACAO; RADIOTERAPIA; OSSIFICACAO HETEROTOPICA; PLASMACITOMA; CONDROSARCOMA; LINFOMA; CORDOMA; HISTIOCITOMA FIBROSO; HEMANGIOENDOTELIOMA; TUMORES DE CELULAS GIGANTES; GRANULOMA EOSINOFILICO |
| 64/194 | US=26-A / Radioterapia Ballo MT, Zagars GK. The soft tissue. In: Cox JD, Ang KK. Radiation oncology: rationale, technique, results. 9ª ed. Philadelphia: Elsevier Mosby, 2010. p. 940-64. ISBN 978-0-323-04971-9. TECIDOS MOLES; SARCOMAS DE TECIDOS MOLES; RADIOTERAPIA; TECNICAS RADIOTERAPICAS; HISTIOCITOMA FIBROSO; SARCOMA SINOVIAL; LIPOSARCOMA; TUMOR DESMOIDE; DERMATOFIBROSARCOMA PROTUBERANS (DFSP); HEMANGIOPERICITOMA |
| 65/194 | US=26-A / Radioterapia Woo SY. Childhood cancer. In: Cox JD, Ang KK. Radiation oncology: rationale, technique, results. 9ª ed. Philadelphia: Elsevier Mosby, 2010. p. 967-89. ISBN 978-0-323-04971-9. CANCER INFANTIL; RADIOTERAPIA; LEUCEMIA AGUDA; TUMOR DE WILM'S; NEUROBLASTOMA; RABDOMIOSARCOMA; RETINOBLASTOMA; CANCER DE FIGADO |
| 66/194 | US=26-A / Radioterapia Firat SY, Lawton CA. Radiation therapy for bone marrow or stem cell transplantation. In: Cox JD, Ang KK. Radiation oncology: rationale, technique, results. 9ª ed. Philadelphia: Elsevier Mosby, 2010. p. 993-1006. ISBN 978-0-323-04971-9. MEDULA OSSEA; TRANSPLANTE DE CELULAS-TRONCO; RADIOTERAPIA; IRRADIACAO TOTAL DO CORPO |
| 67/194 | US=26-A / Radioterapia Janjan NA, Delclos ME, Crane CH. Palliative care. In: Cox JD, Ang KK. Radiation oncology: rationale, technique, results. 9ª ed. Philadelphia: Elsevier Mosby, 2010. p. 1007-35. ISBN 978-0-323-04971-9. CUIDADOS PALIATIVOS; QUALIDADE DE VIDA; CUIDADOS CURATIVOS; DOR NO CANCER; METASTASE OSSEA; METASTASE CEREBRAL; CANCER DE PULMAO; CANCER DE CABECA E PESCOCO; DOENCA PELVICA |
| 68/194 | US=26-A / Radioterapia Cox JD. Proton therapy. In: Cox JD, Ang KK. Radiation oncology: rationale, technique, results. 9ª ed. Philadelphia: Elsevier Mosby, 2010. p. 1036-47. ISBN 978-0-323-04971-9. TERAPIA COM PROTONS; RADIOTERAPIA; TERAPIA DE FEIXE DE PROTONS |
| 69/194 | US=5 / Odontologia Cox CF, Bogen G, Kopel HM, Ruby JD. Reparo das agressões pulpares pelos materiais dentários. In: Hargreaves KM, Goodis HE. Polpa dentária de Seltzer e Bender. São Paulo: Quintessence Editora Ltda, 2009. p. 325-43. ISBN 85-87425-71-3. REPARO DA POLPA; MATERIAIS DENTARIOS; TESTES IN VITRO; TESTES IN VIVO; INFLAMACAO DA POLPA; INFECCAO DA DENTINA; HIDROXIDO DE CALCIO; OXIDO DE ZINCO E EUGENOL; FORMOCRESOL; TRIOXIDO MINERAL; IONOMERO DE VIDRO; SISTEMAS ADESIVOS RESINOSOS |
| 70/194 | US=15 / Biol/Mol Schor SL, Schor AM, Ellis IR, Jones SJ, Florence M, Cox J, Woolston AM. The oncofetal paradigm revisited: MSF and HA as contextual drivers of cancer progression. In: Stern R. Hyaluronan in cancer biology. Amsterdam: Elsevier, 2009. p. 285-306. ISBN 978-0-12-374178-3. CANCER; ACIDO HIALURONICO; MIGRACAO FATOR ESTIMULANTE (MSF); PADRAO ONCOFETAL |
| 71/194 | US=16 / Estatística Bender R. Introduction to the use of regression models in epidemiology. In: Verma M. Cancer epidemiology. New York: Humana Press, 2009. p. 179-95. (Methods in Molecular Biology, 471) ISBN 978-1-58829-987-1. REGRESSAO; REGRESSAO LINEAR; REGRESSAO LOGISTICA; REGRESSAO DE POISSON; REGRESSAO DE COX |
| 72/194 | US=16 / Estatística Xu XC. Risk factors and gene expression in esophageal cancer. In: Verma M. Cancer epidemiology. New York: Humana Press, 2009. p. 335-60. (Methods in Molecular Biology, 471) ISBN 978-1-58829-987-1. CANCER DE ESOFAGO; FATORES DE RISCO; EXPRESSAO GENICA; TABAGISMO; ALCOOLISMO; REFLUXO GASTROESOFAGICO; ALTERACOES GENETICAS; CANCER. PREVENCAO; ESOFAGO DE BARRET; ADENOCARCINOMA ESOFAGICO; MUTACAO DO GENE P53; ALTERACAO DO GENE P16; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMAL (EGFR); CADERINA-E; COX-2; QUIMIOPREVENCAO; ACIDOS RETINOICOS; ANTI-INFLAMATORIOS NAO ESTEROIDES; EGCG; CURCUMINA |
| 73/194 | US=9 / Quimioterapia Ohshima H, Tomono S, Lai YL, Miyoshi N. Inflammation-induced carcinogenesis and chemoprevention. In: Knasmüller S, DeMarini DM, Johnson I, Gerhäuser C. Chemoprevention of cancer and DNA damage by dietary factors. Weinheim: Wiley-VCH, 2009. p. 145-52. ISBN 978-3-527-32058-5. CARCINOGENESE INDUZIDA POR INFLAMACAO; QUIMIOPREVENCAO; FATOR NUCLEAR-KB; INOS; COX-2; ROS |
| 74/194 | US=27 / Clin/Médica FitzGerald GA. Prostaglandinas, aspirina e compostos correlatos. In: Goldman L, Ausiello D, editors. Cecil medicina. 23ª ed. Rio de Janeiro: Elsevier, 2009. p. 231-41. ISBN 85-3523677-4. PROSTAGLANDINA; CICLOOXIGENASE; TROMBOXANO A2; PROSTACICLINA; PROSTAGLANDINA I2; PROSTAGLANDINA D2; PROSTAGLANDINA E2; PROSTAGLANDINA F2-ALFA; ISOEICOSANOIDES; INIBIDORES DE CICLOOXIGENASE; ASPIRINA; ANTI-INFLAMATORIOS NAO ESTEROIDAIS; INIBIDORES DE COX-2 |
| 75/194 | US=35 / Gastro Kiguchi K, DiGiovanni J. Role of growth factor-signaling pathways. In: Thomas CR Junior, Fuller CD. Biliary tract and gallbladder cancer: diagnosis and therapy. New Jersey: DemosMedical, 2009. p. 19-34. ISBN 978-1-933864-42-6. NEOPLASIAS DO TRATO BILIAR; CANCER DE VESICULA BILIAR; FATOR DE CRESCIMENTO; FAMILIA ERBB; RECEPTOR DO FATOR DE CRESCIMENTO INSULIN-LIKE 1; C-MET; MTOR; COX-2 |
| 76/194 | US=60 / Biol/Mol Leung KC, Chen GG. Cyclooxygenase 2 and its metabolites: implications for lung cancer therapy. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 251-72. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; CANCER DE PULMAO; CICLOOXIGENASE 2; PROSTAGLANDINA; COX-2; QUIMIOTERAPIA |
| 77/194 | US=85 / Biol/Mol Hwang JT, Lee YK, Shin JI, Park OJ. Anti-inflammatory and anticarcinogenic effect of genistein alone or in combination with caspsaicin in TPA-treated rat mammary glans or mammary cancer cell line. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 415-20. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5. TRATAMENTO DE COMBINACAO DE GENISTEINA E DE CAPSAICINA; APOPTOSE; COX-2; AMPK; EFEITOS ANTI-INFLAMATORIOS E ANTICARCINOGENICA |
| 78/194 | US=85 / Biol/Mol Kim SY, Jun TW, Lee YS, Na HK, Surh YJ, Song W. Effects of exercise on cyclooxygenase-2 expression and nuclear factor-&*1179;B DNA binding in human peripheral blood mononuclear cells. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 464-71. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5. |
| 79/194 | US=85 / Biol/Mol Lee YK, Park SI, KimYM, Park OJ. Regulatory effect of the AMPK-COX-2 signaling pathway in curcumin-induced apoptosis in HT-29 colon cancer cells. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 489-94. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5. APOPTOSE; CURCUMINA; AKT; AMPK; COX-2; PARADA DO CICLO CELULAR; HT-29COLON CELULAS CANCEROSAS; P53 TIPO SELVAGEM |
| 80/194 | US=85 / Biol/Mol Park IJ, Lee YK, Hwang JT, Kwon DY, Ha J, Park OJ. Green tea catechin controls apoptosis in colon cancer cells by attenuation of H2O2-stimulated COX-2 expression via the AMPK signaling pathway at low-dose H2O2. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 538-44. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5. EGCG; COX-2; AMPK; HT-29 CANCER DE CELULAS DO COLON; BAIXAS DOSES DE H2O2; APOPTOSE; P53 TIPO SELVAGEM |